|Lance A. Liotta, M.D., Ph.D.|
Lance Liotta, M.D., Ph.D., is co-director of the George Mason University (GMU) Center for Applied Proteomics and Molecular Medicine, professor of life sciences, and medical director of the GMU Clinical Proteomics Laboratory.
Liotta also was formerly chief of the laboratory of pathology at the National Cancer Institute, co-director of the NCI-FDA Clinical Proteomics Program, and deputy director for Intramural Research at NIH.
Liotta received his M.D. and Ph.D. degrees from Case Western Reserve University in 1976.
He has invented technology in the fields of diagnostics, immunoassays, microdissection, and proteomics.
Liotta has more than 80 patents and 600 publications. He and his colleagues in the laboratory of pathology invented laser capture microdissection, which has been commercialized and is used in more than 1,000 labs worldwide.
|The microecology of ductal carcinoma in situ (DCIS) lesions in the breast. The stressful microenvironment of the intraductal niche may promote genetic instability. (Espina V. and Liotta L., Nat. Rev. Cancer 11:68-75, 2011)|